tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

EXEL Stock Latest News

Exelixis Advances Cancer Treatment with New Phase 1 Study of XL309
Company AnnouncementsExelixis Advances Cancer Treatment with New Phase 1 Study of XL309
3d ago
EXEL
Exelixis price target raised to $56 from $55 at Truist
PremiumThe Fly
Exelixis price target raised to $56 from $55 at Truist
5d ago
EXEL
Exelixis’ Phase 3 Trial: A New Hope for Renal Cell Carcinoma?
PremiumCompany Announcements
Exelixis’ Phase 3 Trial: A New Hope for Renal Cell Carcinoma?
6d ago
EXEL
Exelixis price target raised to $43 from $38 at UBS
PremiumThe Fly
Exelixis price target raised to $43 from $38 at UBS
9d ago
EXEL
Exelixis price target raised to $40 from $29 at Barclays
PremiumThe Fly
Exelixis price target raised to $40 from $29 at Barclays
10d ago
EXEL
Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
PremiumCompany AnnouncementsPan-Tumor Rollover Study: A New Horizon in Cancer Treatment
11d ago
BMY
NVS
RBC downgrades Exelixis on valuation ahead of Cabometyx cliff
Premium
The Fly
RBC downgrades Exelixis on valuation ahead of Cabometyx cliff
12d ago
EXEL
Exelixis downgraded to Sector Perform from Outperform at RBC Capital
Premium
The Fly
Exelixis downgraded to Sector Perform from Outperform at RBC Capital
12d ago
EXEL
Truist biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Truist biotech analyst holds an analyst/industry conference call
17d ago
JNJ
EXEL
Exelixis price target raised to $53 from $47 at H.C. Wainwright
PremiumThe Fly
Exelixis price target raised to $53 from $47 at H.C. Wainwright
20d ago
EXEL
Exelixis’s Promising STELLAR-303 Trial Results Lead to Buy Rating and Increased Approval Probability
PremiumRatings
Exelixis’s Promising STELLAR-303 Trial Results Lead to Buy Rating and Increased Approval Probability
20d ago
EXEL
NuScale, Hims & Hers, Snowflake, Advance Auto Parts, Exelixis: Trending by Analysts
PremiumWeekend Updates
NuScale, Hims & Hers, Snowflake, Advance Auto Parts, Exelixis: Trending by Analysts
22d ago
AAP
SMR
Exelixis price target raised to $50 from $42 at Jefferies
PremiumThe FlyExelixis price target raised to $50 from $42 at Jefferies
26d ago
EXEL
Lyft upgraded, Block assumed: Wall Street’s top analyst calls
Premium
The Fly
Lyft upgraded, Block assumed: Wall Street’s top analyst calls
26d ago
EA
RH
Cautious Hold Rating for Exelixis Amid STELLAR-303 Trial Results and Regulatory Concerns
Premium
Ratings
Cautious Hold Rating for Exelixis Amid STELLAR-303 Trial Results and Regulatory Concerns
26d ago
EXEL
Exelixis upgraded to Overweight, named new ‘Best Idea’ at Stephens
PremiumThe Fly
Exelixis upgraded to Overweight, named new ‘Best Idea’ at Stephens
26d ago
EXEL
Exelixis upgraded to Overweight from Equal Weight at Stephens
PremiumThe Fly
Exelixis upgraded to Overweight from Equal Weight at Stephens
26d ago
EXEL
More data needed to determine Exelixis’ competitive positioning, says BofA
PremiumThe Fly
More data needed to determine Exelixis’ competitive positioning, says BofA
27d ago
EXEL
Exelixis price target raised to $55 from $43 at Truist
PremiumThe Fly
Exelixis price target raised to $55 from $43 at Truist
27d ago
EXEL
Exelixis price target raised to $50 from $47 at Citizens JMP
PremiumThe FlyExelixis price target raised to $50 from $47 at Citizens JMP
27d ago
EXEL
Exelixis: Promising Clinical Trial Success and Strong Future Prospects Drive Buy Rating
Premium
Ratings
Exelixis: Promising Clinical Trial Success and Strong Future Prospects Drive Buy Rating
27d ago
EXEL
Exelixis announces ‘positive’ results from STELLAR-303 phase 3 trial
Premium
The Fly
Exelixis announces ‘positive’ results from STELLAR-303 phase 3 trial
28d ago
EXEL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >